ZA897421B - Process for the micronization of glibenolamide - Google Patents
Process for the micronization of glibenolamideInfo
- Publication number
- ZA897421B ZA897421B ZA897421A ZA897421A ZA897421B ZA 897421 B ZA897421 B ZA 897421B ZA 897421 A ZA897421 A ZA 897421A ZA 897421 A ZA897421 A ZA 897421A ZA 897421 B ZA897421 B ZA 897421B
- Authority
- ZA
- South Africa
- Prior art keywords
- glibenclamide
- glibenolamide
- micronization
- microfine
- entails
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/59—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A process for preparing a micronised form of glibenclamide of the formula <IMAGE> with a BET surface area of the active compound particles of at least 3 m<2>/g is described. It entails a suspension of a sparingly soluble salt of glibenclamide in water being acidified with an acid. The result is a microfine precipitate of glibenclamide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3833439A DE3833439A1 (en) | 1988-10-01 | 1988-10-01 | METHOD FOR MICRONIZING GLIBENCLAMIDE |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA897421B true ZA897421B (en) | 1990-06-27 |
Family
ID=6364187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA897421A ZA897421B (en) | 1988-10-01 | 1989-09-29 | Process for the micronization of glibenolamide |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0362704B2 (en) |
JP (1) | JPH02149516A (en) |
AT (1) | ATE89268T1 (en) |
AU (1) | AU620448B2 (en) |
DE (2) | DE3833439A1 (en) |
ES (1) | ES2057043T5 (en) |
FI (1) | FI894598A (en) |
GR (1) | GR3020754T3 (en) |
NZ (1) | NZ230828A (en) |
PT (1) | PT91835A (en) |
ZA (1) | ZA897421B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE250418T1 (en) | 1998-07-15 | 2003-10-15 | Merck Sante Sas | TABLETS CONTAINING A COMBINATION OF GLIBENCLAMIDE AND METFORMIN |
US6586438B2 (en) | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
HU229352B1 (en) * | 1999-11-03 | 2013-11-28 | Bristol Myers Squibb Co | Medicament comprising the combination of metformin and glyburide |
US20010036479A1 (en) | 2000-01-14 | 2001-11-01 | Gillian Cave | Glyburide composition |
WO2009073711A1 (en) | 2007-12-04 | 2009-06-11 | Remedy Pharmaceuticals, Inc. | Improved formulations and methods for lyophilization and lyophilates provided thereby |
DE102008000351B4 (en) | 2008-02-20 | 2017-08-10 | Aristo Pharma Gmbh | Process for the preparation of an ebastine-containing granule and a solid pharmaceutical composition, ebastine-containing granules and its use |
FR2987268B1 (en) | 2012-02-28 | 2014-07-11 | Ammtek | LIQUID FORMULATIONS OF HYPOGLYCEMIC SULFAMIDES |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD91647A (en) * | ||||
DE1301812B (en) * | 1965-07-27 | 1969-08-28 | Hoechst Ag | Process for the preparation of benzenesulfonylureas |
CA889876A (en) * | 1970-09-10 | 1972-01-04 | Frank W. Horner Limited | Purification of glyburide |
NL7314765A (en) * | 1972-10-31 | 1974-05-02 | ||
DE2348334C2 (en) * | 1973-09-26 | 1982-11-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | New form of preparation of N-4- [2- (5-chloro-2-methoxybenzamido) ethyl] -phenyl-sulfonyl-N'-cyclohexylurea |
DD204915B1 (en) * | 1981-12-16 | 1986-05-07 | Goldner Richard | METHOD OF PREPARING PURE N- (4- (BETA-WELDED BRACKET ON 2-METHOXY-5-CHLORO-BENZAMIDO WELDED BRACKET TO -ETHYL) -PHENYLSULFONYL) -N'-CYCLOHEXYL HARDILLARY |
DD248115A1 (en) * | 1984-04-11 | 1987-07-29 | Dresden Arzneimittel | METHOD OF PREPARING N- (4- (SS-5-CHLORO-2-METHOXY-BENZAMIDO-ETHHYL) -PHENYLSULFONYL) -N'-CYCLOHEXYL HARNON IN FINE DISTRIBUTION |
RO89209A2 (en) * | 1984-06-12 | 1986-05-30 | Intreprinderea De Medicamente Si Coloranti"Sintofarm",Ro | PROCESS FOR OBTAINING GLYBENCLAMIDE |
-
1988
- 1988-10-01 DE DE3833439A patent/DE3833439A1/en not_active Withdrawn
-
1989
- 1989-09-28 FI FI894598A patent/FI894598A/en not_active Application Discontinuation
- 1989-09-28 EP EP89117998A patent/EP0362704B2/en not_active Expired - Lifetime
- 1989-09-28 AU AU42302/89A patent/AU620448B2/en not_active Ceased
- 1989-09-28 AT AT89117998T patent/ATE89268T1/en not_active IP Right Cessation
- 1989-09-28 DE DE8989117998T patent/DE58904332D1/en not_active Expired - Lifetime
- 1989-09-28 ES ES89117998T patent/ES2057043T5/en not_active Expired - Lifetime
- 1989-09-28 PT PT91835A patent/PT91835A/en unknown
- 1989-09-29 ZA ZA897421A patent/ZA897421B/en unknown
- 1989-09-29 JP JP1252475A patent/JPH02149516A/en active Pending
- 1989-09-29 NZ NZ230828A patent/NZ230828A/en unknown
-
1996
- 1996-08-08 GR GR960401977T patent/GR3020754T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE89268T1 (en) | 1993-05-15 |
EP0362704B1 (en) | 1993-05-12 |
PT91835A (en) | 1990-04-30 |
EP0362704B2 (en) | 1996-08-07 |
AU620448B2 (en) | 1992-02-20 |
ES2057043T3 (en) | 1994-10-16 |
EP0362704A1 (en) | 1990-04-11 |
AU4230289A (en) | 1990-04-05 |
JPH02149516A (en) | 1990-06-08 |
DE3833439A1 (en) | 1991-09-12 |
DE58904332D1 (en) | 1993-06-17 |
ES2057043T5 (en) | 1996-11-01 |
GR3020754T3 (en) | 1996-11-30 |
NZ230828A (en) | 1991-07-26 |
FI894598A (en) | 1990-04-02 |
FI894598A0 (en) | 1989-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2041168A1 (en) | Use of alkylcarboxylic acid dimethylamides as crystallization inhibitors | |
EG19153A (en) | Serine analogs of bu - 3608 antibiotics | |
ZA897421B (en) | Process for the micronization of glibenolamide | |
ES2001341A6 (en) | Novel guanidinomethylbenzoic acid derivatives. | |
FR2688506B1 (en) | PROCESS FOR THE PREPARATION OF SALTS OF CLAVULANIC ACID. | |
BG42835A3 (en) | Method for preparing derivatives of thiazolylacetic acid | |
IL104791A0 (en) | 4-amino-2-ureidopyrimidine-5-carboxamides,a process for the preparation thereof,pharmaceuticals containing these compounds and the use thereof | |
AU7625387A (en) | A process for preparing cimetidine polymorph B. | |
AU584336B2 (en) | New cephalosporins and processes for their preparation | |
ES8502118A1 (en) | Penicillin derivatives and process for preparation of the same. | |
DE3160345D1 (en) | Alcoxy-propanol amines useful as medicines, and process for their preparation | |
GB2019843A (en) | N-Alkenylmoranoline derivatives | |
HU912216D0 (en) | Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them | |
FR2632643B1 (en) | NOVEL PROCESS FOR THE PREPARATION OF N- (VINBLASTINOYL-23) DERIVATIVES OF 1-AMINO METHYLPHOSPHONIC ACID | |
IE800882L (en) | Oxa-beta-lactam derivative | |
EP0397048A3 (en) | Process for the preparation of 2-mercapto-4-methyl-1,3-thiazol-5-yl acetic acid and its esters | |
GB8410992D0 (en) | Process | |
CS274910B2 (en) | Method of 2-(aminoalkylthio) carbapeneme preparation | |
EP0298502A3 (en) | Cephem derivative crystals and a process for their preparation |